Urbanek David Alan 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Urbanek David Alan
See Remarks
Transactions
- Tax Payment
Common Stock
2022-03-01$28.94/sh−1,800$52,092→ 93,319 total - Tax Payment
Common Stock
2022-03-02$29.00/sh−961$27,869→ 92,358 total - Award
Employee Stock Option(right to buy)
2022-03-01+27,480→ 27,480 totalExercise: $28.94Exp: 2032-03-01→ Common Stock (27,480 underlying) - Award
Common Stock
2022-03-01+10,341→ 95,119 total
Footnotes (3)
- [F1]Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
- [F2]Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
- [F3]Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.